Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

✍ Scribed by Cahn, Pedro; Andrade-Villanueva, Jaime; Arribas, José R; Gatell, José M; Lama, Javier R; Norton, Michael; Patterson, Patricia; Madero, Juan Sierra; Sued, Omar; Figueroa, Maria Inés; Rolon, Maria José

• Book ID: 123414744
• Publisher: The Lancet
• Year: 2014
• Tongue: English
• Weight: 321 KB
• Volume: 14
• Category: Article
• ISSN: 1473-3099
• DOI: 10.1016/S1473-3099(14)70736-4